Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 17, 2025
Endoscopic endonasal versus open approach for craniopharyngioma treatment: a systematic review of clinical characteristicsGeena Jung, Joshua M Cohen, David Oriko, et al.Neurology|August 5, 2020
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B Lipton, Joshua M Cohen, Sanjay K Gandhi, et al.Journal of Managed Care & Specialty Pharmacy|July 18, 2020
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for MigraineDawn C Buse, Marianna S Yugrakh, Lulu K Lee, et al.Plastic and Reconstructive Surgery. Global Open|October 30, 2023
Preauthorization Inconsistencies Prevail in Reduction MammaplastyCarter J Boyd, Kshipra Hemal, Joshua M Cohen, et al.Journal of Clinical Medicine|August 12, 2022
Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive TreatmentsGeorge R Nissan, Richard Kim, Joshua M Cohen, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 2021
Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. "Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials". Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819-828. Epublished November 2020Steve Barash, Verena Ramirez Campos, Xiaoping Ning, et al.Plastic and Reconstructive Surgery|February 2, 2023
Gender Considerations in RhinoplastyAbigail M Rodriguez, Ira L Savetsky, Joshua M Cohen, et al.The Journal of Headache and Pain|April 17, 2021
Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trialEgilius L H Spierings, Mikko Kärppä, Xiaoping Ning, et al.Headache|September 2, 2017
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive MedicinesJoshua M Cohen, David W Dodick, Ronghua Yang, et al.The Journal of Headache and Pain|September 5, 2020
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey studyDawn C Buse, Sanjay K Gandhi, Joshua M Cohen, et al.Pageof 9